Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$852K Buy
35,409
+1,580
+5% +$41.3K 0.1% 156
2026
Q1
$950K Buy
33,829
+706
+2% +$18.8K 0.12% 151
2025
Q4
$824K Sell
33,123
-1,043
-3% -$26.3K 0.1% 163
2025
Q3
$870K Sell
34,166
-1,826
-5% -$45.1K 0.11% 162
2025
Q2
$872K Sell
35,992
-232
-0.6% -$5.41K 0.11% 163
2025
Q1
$918K Buy
36,224
+2,352
+7% +$61.5K 0.13% 161
2024
Q4
$898K Buy
33,872
+236
+0.7% +$6.4K 0.13% 162
2024
Q3
$973K Buy
33,636
+3,726
+12% +$109K 0.14% 155
2024
Q2
$837K Buy
29,910
+4,744
+19% +$131K 0.12% 160
2024
Q1
$698K Buy
25,166
+272
+1% +$7.55K 0.1% 178
2023
Q4
$717K Sell
24,894
-3,520
-12% -$106K 0.12% 166
2023
Q3
$942K Sell
28,414
-5,194
-15% -$184K 0.17% 135
2023
Q2
$1.23M Buy
33,608
+702
+2% +$27.3K 0.21% 116
2023
Q1
$1.34M Sell
32,906
-768
-2% -$33.2K 0.24% 109
2022
Q4
$1.73M Sell
33,674
-1,130
-3% -$54.2K 0.32% 87
2022
Q3
$1.52M Buy
34,804
+1,500
+5% +$72.9K 0.3% 90
2022
Q2
$1.75M Buy
33,304
+1,203
+4% +$61.3K 0.33% 87
2022
Q1
$1.66M Sell
32,101
-565
-2% -$29.3K 0.27% 101
2021
Q4
$1.53M Sell
32,666
-1,423
-4% -$70.5K 0.26% 103
2021
Q3
$1.47M Sell
34,089
-794
-2% -$35.2K 0.25% 107
2021
Q2
$1.37M Sell
34,883
-1,041
-3% -$40.5K 0.24% 106
2021
Q1
$1.3M Sell
35,924
-2,620
-7% -$93K 0.25% 108
2020
Q4
$1.42M Sell
38,544
-3,863
-9% -$142K 0.3% 99
2020
Q3
$1.48M Buy
42,407
+4,923
+13% +$173K 0.34% 96
2020
Q2
$1.16M Buy
37,484
+369
+1% +$12.5K 0.29% 105
2020
Q1
$1.15M Sell
37,115
-377
-1% -$12.8K 0.35% 93
2019
Q4
$1.39M Sell
37,492
-59,021
-61% -$2.1M 0.33% 95
2019
Q3
$3.29M Buy
96,513
+1,082
+1% +$39.3K 0.85% 36
2019
Q2
$3.92M Sell
95,431
-49
-0.1% -$1.95K 1.06% 24
2019
Q1
$3.85M Buy
95,480
+3,077
+3% +$123K 1.08% 24
2018
Q4
$3.83M Sell
92,403
-129
-0.1% -$5.36K 1.25% 17
2018
Q3
$3.87M Buy
92,532
+967
+1% +$37.2K 1.11% 20
2018
Q2
$3.15M Buy
91,565
+644
+0.7% +$22K 0.97% 28
2018
Q1
$3.06M Buy
90,921
+3,466
+4% +$119K 0.98% 28
2017
Q4
$3M Buy
87,455
+2,398
+3% +$81.8K 0.95% 29
2017
Q3
$2.88M Buy
85,057
+2,459
+3% +$79K 0.96% 27
2017
Q2
$2.63M Buy
82,598
+11,374
+16% +$359K 0.93% 31
2017
Q1
$2.31M Buy
71,224
+2,610
+4% +$82.3K 0.87% 32
2016
Q4
$2.11M Buy
68,614
+6,962
+11% +$213K 0.82% 33
2016
Q3
$1.98M Buy
61,652
+5,701
+10% +$191K 0.86% 33
2016
Q2
$1.87M Buy
55,951
+3,831
+7% +$122K 0.83% 33
2016
Q1
$1.47M Buy
52,120
+2,714
+5% +$77.5K 0.73% 43
2015
Q4
$1.51M Sell
49,406
-78
-0.2% -$2.45K 0.78% 40
2015
Q3
$1.47M Buy
49,484
+981
+2% +$31.5K 0.8% 36
2015
Q2
$1.54M Sell
48,503
-232
-0.5% -$7.56K 0.79% 42
2015
Q1
$1.61M Buy
48,735
+661
+1% +$21K 0.82% 39
2014
Q4
$1.42M Buy
48,074
+3,722
+8% +$107K 0.75% 45
2014
Q3
$1.24M Sell
44,352
-422
-0.9% -$11.8K 0.69% 53
2014
Q2
$1.22M Buy
44,774
+6,054
+16% +$173K 0.7% 49
2014
Q1
$1.18M Sell
38,720
-685
-2% -$20.4K 0.72% 50
2013
Q4
$1.15M Buy
+39,405
New +$1.15M 0.72% 50

Other funds holding PFE

City Holding Co's PFE Position: Q2 2026 in Review

City Holding Co increased its Pfizer (PFE) stake by 4.7% in Q2 2026, buying an estimated $41.3K and bringing the position to 35,409 shares worth $852K. The position accounts for 0.1% of the portfolio, ranked #156.

City Holding Co first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.92M in Q2 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • City Holding Co held 35,409 shares of Pfizer worth $852K as of Q2 2026.
  • City Holding Co bought 1,580 Pfizer shares in Q2 2026, an estimated $41.3K.
  • Pfizer made up 0.1% of City Holding Co's portfolio in Q2 2026, its #156 holding.
  • City Holding Co first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • City Holding Co's Pfizer position peaked at $3.92M in Q2 2019.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on City Holding Co's 13F filing for Q2 2026, filed 10 Jul 2026.